InvestorsHub Logo
Followers 46
Posts 1364
Boards Moderated 0
Alias Born 08/09/2015

Re: wildcard235 post# 315882

Sunday, 06/20/2021 9:06:08 AM

Sunday, June 20, 2021 9:06:08 AM

Post# of 470015
Thank you for the excellent post. As a long-term Anavex shareholder, I witnessed the short attacks to which you refer. I also remember reading your Seeking Alpha Article that you site at the end of the above post. Anavex endured brutal attacks every time it reported positive news from clinical trials. Additionally, several law firms filed securities class action lawsuits against Anavex wherein quotes from the false articles about Anavex were quoted supporting the litigation. Anavex was set back in conducting its clinical trials because it could not raise the money it needed due to its low share price. We are in a better position now. Clinical trials are well advanced, Anavex has raised capital and is in a place to raise more, articles about Anavex are positive, and shorts are subject to being burned again, as you point out. If and when we get good news from clinical trials, the share price should react differently and not get knocked down as in the past. Of course, we all know what happens if clinical trial results are not up to investor expectations, but that is legitimate - the short attacks of the past were not.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News